DELTALIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Deltalin, and what generic alternatives are available?
Deltalin is a drug marketed by Lilly and is included in one NDA.
The generic ingredient in DELTALIN is ergocalciferol. There are six drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the ergocalciferol profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Deltalin
A generic version of DELTALIN was approved as ergocalciferol by CHARTWELL RX on May 20th, 2009.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DELTALIN?
- What are the global sales for DELTALIN?
- What is Average Wholesale Price for DELTALIN?
Summary for DELTALIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 82 |
| Patent Applications: | 3,434 |
| DailyMed Link: | DELTALIN at DailyMed |
US Patents and Regulatory Information for DELTALIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lilly | DELTALIN | ergocalciferol | CAPSULE;ORAL | 080884-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
